The Ultimate Directory on Pharmaceutical Webinars

Circulating tumor DNA (ctDNA) profiling is increasingly used in solid tumor management to inform a variety of clinical research questions. ctDNA supports non-invasive testing for trial enrollment and longitudinal monitoring. It has potential applications in clinical study design, prognostication, and understanding when de-escalation may be possible.In this seminar, Valsamo Anagnostou of John Hopkins University will discuss implications in assessing ctDNA in advanced cancer given variable shed in patients, as well as considerations in selecting an approach. She will highlight data demonstrating the value of ctDNA dynamics and recently initiated clinical trials leveraging response-adaptive study designs and how this information can support clinical research to guide patient care.Mia Levy, chief medical officer at Foundation Medicine, will present clinical analysis for Foundation Medicine’s ctDNA tumor fraction method and how it can be leveraged for studies using only liquid biopsy to provide confidence in a negative result, support risk stratification, response-adaptive study designs, and dose selection. She will also highlight how the Foundation Medicine portfolio can support clinical studies leveraging ctDNA.The speakers will discuss:ctDNA-driven interventional clinical trials in immune-oncology based on molecular response.Response-adaptive study designs for targeted therapies.Early-phase clinical studies using ctDNA to support dose selection or early go/no go decisions.The clinical insights provided by Foundation Medicine’s ctDNA tumor fraction and portfolio of solutions for supporting clinical research and drug development.

Discover a groundbreaking webinar delving into advancements in antibody-drug conjugates (ADCs) and related patent filings. Antibody-drug conjugates are among the most promising drug classes in oncology...

Ever since regulatory agencies globally mandate pediatric clinical trials for drugs intended for pediatric use, there has been a significant increase in the number of industrially sponsored pediatric clinical trials in recent years. This webinar examines the world of pediatric dosage forms and how orally disintegrating tablets (ODTs) are emerging as a specialized drug delivery system for children.Featured speakers include: Prof. Afzal Mohammed from Aston University, and Leon Grother, Formulation Manager at Catalent.

Mushrooms have been used in medicinal and spiritual practices by Indigenous cultures around the world. This webinar will discuss the pharmacology and chemistry of psychedelic alkaloids found in the fungi kingdom and their use in psychedelic medicine.

From Lead Candidate to GMP Manufacture - Navigating the Drug Substance Development Journey is a webinar that will take place on 7 December at 3PM GMT / 10AM EST. Register now for free to learn more about the topic.